Clinical Trial: A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07331402) titled 'A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients' on Aug. 20, 2025.

Brief Summary: This is a random, single blind, positive control, crossover design clinical study to evaluate the pharmacokinetics and pharmacodynamics of HSK39004 inhalation suspension in COPD patients

Study Start Date: July 28, 2025

Study Type: INTERVENTIONAL

Condition: COPD Patients

Intervention: DRUG: HSK39004 inhalation suspension

HSK39004 inhalation suspension , Inhale through the mouth, 3mg each time, twice a day; Ohtuvayre inhalation suspension, Inhale through the mouth, 3mg each t...